Intra-Cellular Therapies, Inc.
ORGANIC COMPOUND

Abstract:

The invention relates to a particular substituted heterocycle fused gamma-carboline, in free, or pharmaceutically acceptable salt, and/or substantially pure form as described herein, pharmaceutical compositions thereof, and methods of use in the treatment of diseases involving the 5-HT.sub.2A receptor, the serotonin transporter (SERT), and/or pathways involving the dopamine D.sub.1 and D.sub.2 receptor signaling system.